Cargando…

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage

BACKGROUND: A substantial share of type 2 diabetes mellitus (T2DM) patients receive insulin. However, little is known about the real-world treatment patterns around insulin initiation. METHODS: This was a retrospective claims data analysis. T2DM patients who initiated an insulin therapy between 01/0...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilke, Thomas, Picker, Nils, Mueller, Sabrina, Geier, Silke, Foersch, Johannes, Aberle, Jens, Martin, Stephan, Riedl, Matthias, Gabler, Maximilian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664320/ https://www.ncbi.nlm.nih.gov/pubmed/31440070 http://dx.doi.org/10.2147/DMSO.S214288

Ejemplares similares

Guideline Adherence and Associated Outcomes in the Treatment of Type 2 Diabetes Mellitus Patients With an Incident Cardiovascular Comorbidity: An Analysis Based on a Large German Claims Dataset
por: Gabler, Maximilian, et al.
Publicado: (2021)

Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds
por: Wilke, Thomas, et al.
Publicado: (2022)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
Publicado: (2019)

Cardiovascular disease prevalence in type 2 diabetes – an analysis of a large German statutory health insurance database
por: Gabler, Maximilian, et al.
Publicado: (2021)

Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis
por: Wilke, Thomas, et al.
Publicado: (2020)

Background Factors Determining the Introduction and Dosage of Insulin in Women With Gestational Diabetes Mellitus
por: Matsumoto, Yuko, et al.
Publicado: (2019)

Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
por: Buhl, Roland, et al.
Publicado: (2022)

Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data
por: Bokemeyer, Bernd, et al.
Publicado: (2022)

Relationship of Vitamin D level with insulin dosage required based on insulin therapy protocol
por: Lahiji, Mohammad Niakan, et al.
Publicado: (2023)

Assessment of knowledge among caregivers of diabetic patients in insulin dosage regimen and administration
por: Alnaim, Lamya, et al.
Publicado: (2021)

Liver disease epidemiology and burden in patients with alterations in plasma protein metabolism: German retrospective insurance claims analysis
por: Picker, Nils, et al.
Publicado: (2023)

Modern insulin and insulin therapy in diabetes mellitus.
por: Montgomery, D. A.
Publicado: (1978)

Association between insulin dosage and insulin usage time, and coronary artery lesions in patients with type 2 diabetes and coronary heart disease
por: LUO, XIAO-LI, et al.
Publicado: (2016)

Insulin Secretory Capacity and Insulin Resistance in Korean Type 2 Diabetes Mellitus Patients
por: Kim, Jong-Dai, et al.
Publicado: (2016)

Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
por: Ucieklak, Damian, et al.
Publicado: (2022)

Feasibility of a Mobile Phone–Based Data Service for Functional Insulin Treatment of Type 1 Diabetes Mellitus Patients
por: Kollmann, Alexander, et al.
Publicado: (2007)

The Optimized Calculation Method for Insulin Dosage in an Insulin Tolerance Test (ITT): A Randomized Parallel Control Study
por: Zhang, Yuwen, et al.
Publicado: (2020)

Insulin aspart in patients with gestational diabetes mellitus and pregestational diabetes mellitus
por: Deepaklal, M. C., et al.
Publicado: (2015)

IoT Based Expert System for Diabetes Diagnosis and Insulin Dosage Calculation
por: Valsalan, Prajoona, et al.
Publicado: (2022)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

The Insulin Treatment of Diabetes Mellitus
Publicado: (1924)

Pancreatic Insulin in Diabetes Mellitus
por: Turtle, John R.
Publicado: (1971)

Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study
por: Wu, Jianmin, et al.
Publicado: (2021)

Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
por: Evans, Marc, et al.
Publicado: (2017)

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
por: Kusunoki, Yoshiki, et al.
Publicado: (2013)

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
por: Shafie, Asrul Akmal, et al.
Publicado: (2020)

The psychometric properties of the barriers to insulin treatment questionnaire in Chinese patients with type 2 diabetes mellitus using insulin
por: Ma, Min, et al.
Publicado: (2023)

THU328 Appropriate Initial Insulin Dosage For Management Of Steroid-induced Hyperglycemia In Hospitalized COVID-19 Patients
por: Ketaroonrut, Nuttavadee, et al.
Publicado: (2023)

Regular insulin, rather than rapid‐acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus
por: Kuroda, Akio, et al.
Publicado: (2013)

Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study
por: Duque, Natalia, et al.
Publicado: (2021)

Insulin Resistance in Patients With Acromegaly
por: Vila, Greisa, et al.
Publicado: (2019)

Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus
por: Yoon, Kun-Ho, et al.
Publicado: (2017)

A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
por: Pan, Changyu, et al.
Publicado: (2016)

Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy
por: Dündar, Bumin Nuri, et al.
Publicado: (2009)

Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients
por: Ramakrishna, Vadde, et al.
Publicado: (2007)

Evaluation of hearing loss in juvenile insulin dependent patients with diabetes mellitus
por: Okhovat, Sayyed Ahmadreza, et al.
Publicado: (2011)

Immunoglobulin A nephropathy in patients with non-insulin dependent diabetes mellitus.
por: Lee, E. Y., et al.
Publicado: (1999)

The Prevalence of Gastrointestinal Symptoms in Patients with Non-Insulin Dependent Diabetes Mellitus
por: Oh, Jung-Hwan, et al.
Publicado: (2009)

Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients
por: Kubo, Sayaka, et al.
Publicado: (2010)

Melioidosis in a patient with type 1 diabetes mellitus on an insulin pump
por: Katz, Melissa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fv9q5mgrv7sbai3eubfbm10j6k